2018-2023 Global Antivenom Consumption Market Report

September 2018 | 134 pages | ID: 22EDEC1888AEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Antivenom market for 2018-2023.

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
Asia-Pacific Antivenom market is valued at 285.00 million USD in 2017 and is expected to reach 359.23 million USD by the end of 2023, growing at a CAGR of 43.93% between 2016 and 2022.
The price of Antivenom is slightly increased in nearly five years. For being accorded with the corresponding application area, the product price has a large differences.
Despite the presence of competition problems, due to the global recovery trend is clear, investors are still optimistic about this areas, the future will still have more new investment enter the field.
Over the next five years, LPI(LP Information) projects that Antivenom will register a 2.5% CAGR in terms of revenue, reach US$ 960 million by 2023, from US$ 830 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Antivenom market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Polyvalent antivenom
• Monovalent antivenom

Segmentation by application:

• Retail Pharmacies
• Hospitals
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• CSL Behring
• Merck & Co., Inc.
• BTG Plc
• Pfizer
• Haffkine Bio-Pharmaceutical Corporation
• Rare Disease Therapeutics
• Flynn Pharma
• Vins Bioproducts
• Bharat Serums and Vaccines
• Serum Biotech

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Antivenom consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Antivenom market by identifying its various subsegments.
• Focuses on the key global Antivenom manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Antivenom with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Antivenom submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Antivenom Consumption 2013-2023
  2.1.2 Antivenom Consumption CAGR by Region
2.2 Antivenom Segment by Type
  2.2.1 Polyvalent antivenom
  2.2.2 Monovalent antivenom
2.3 Antivenom Consumption by Type
  2.3.1 Global Antivenom Consumption Market Share by Type (2013-2018)
  2.3.2 Global Antivenom Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Antivenom Sale Price by Type (2013-2018)
2.4 Antivenom Segment by Application
  2.4.1 Retail Pharmacies
  2.4.2 Hospitals
  2.4.3 Others
2.5 Antivenom Consumption by Application
  2.5.1 Global Antivenom Consumption Market Share by Application (2013-2018)
  2.5.2 Global Antivenom Value and Market Share by Application (2013-2018)
  2.5.3 Global Antivenom Sale Price by Application (2013-2018)

3 GLOBAL ANTIVENOM BY PLAYERS

3.1 Global Antivenom Sales Market Share by Players
  3.1.1 Global Antivenom Sales by Players (2016-2018)
  3.1.2 Global Antivenom Sales Market Share by Players (2016-2018)
3.2 Global Antivenom Revenue Market Share by Players
  3.2.1 Global Antivenom Revenue by Players (2016-2018)
  3.2.2 Global Antivenom Revenue Market Share by Players (2016-2018)
3.3 Global Antivenom Sale Price by Players
3.4 Global Antivenom Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Antivenom Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Antivenom Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 ANTIVENOM BY REGIONS

4.1 Antivenom by Regions
  4.1.1 Global Antivenom Consumption by Regions
  4.1.2 Global Antivenom Value by Regions
4.2 Americas Antivenom Consumption Growth
4.3 APAC Antivenom Consumption Growth
4.4 Europe Antivenom Consumption Growth
4.5 Middle East & Africa Antivenom Consumption Growth

5 AMERICAS

5.1 Americas Antivenom Consumption by Countries
  5.1.1 Americas Antivenom Consumption by Countries (2013-2018)
  5.1.2 Americas Antivenom Value by Countries (2013-2018)
5.2 Americas Antivenom Consumption by Type
5.3 Americas Antivenom Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Antivenom Consumption by Countries
  6.1.1 APAC Antivenom Consumption by Countries (2013-2018)
  6.1.2 APAC Antivenom Value by Countries (2013-2018)
6.2 APAC Antivenom Consumption by Type
6.3 APAC Antivenom Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Antivenom by Countries
  7.1.1 Europe Antivenom Consumption by Countries (2013-2018)
  7.1.2 Europe Antivenom Value by Countries (2013-2018)
7.2 Europe Antivenom Consumption by Type
7.3 Europe Antivenom Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Antivenom by Countries
  8.1.1 Middle East & Africa Antivenom Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Antivenom Value by Countries (2013-2018)
8.2 Middle East & Africa Antivenom Consumption by Type
8.3 Middle East & Africa Antivenom Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Antivenom Distributors
10.3 Antivenom Customer

11 GLOBAL ANTIVENOM MARKET FORECAST

11.1 Global Antivenom Consumption Forecast (2018-2023)
11.2 Global Antivenom Forecast by Regions
  11.2.1 Global Antivenom Forecast by Regions (2018-2023)
  11.2.2 Global Antivenom Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Antivenom Forecast by Type
11.8 Global Antivenom Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 CSL Behring
  12.1.1 Company Details
  12.1.2 Antivenom Product Offered
  12.1.3 CSL Behring Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 CSL Behring News
12.2 Merck & Co., Inc.
  12.2.1 Company Details
  12.2.2 Antivenom Product Offered
  12.2.3 Merck & Co., Inc. Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Merck & Co., Inc. News
12.3 BTG Plc
  12.3.1 Company Details
  12.3.2 Antivenom Product Offered
  12.3.3 BTG Plc Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 BTG Plc News
12.4 Pfizer
  12.4.1 Company Details
  12.4.2 Antivenom Product Offered
  12.4.3 Pfizer Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Pfizer News
12.5 Haffkine Bio-Pharmaceutical Corporation
  12.5.1 Company Details
  12.5.2 Antivenom Product Offered
  12.5.3 Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Haffkine Bio-Pharmaceutical Corporation News
12.6 Rare Disease Therapeutics
  12.6.1 Company Details
  12.6.2 Antivenom Product Offered
  12.6.3 Rare Disease Therapeutics Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Rare Disease Therapeutics News
12.7 Flynn Pharma
  12.7.1 Company Details
  12.7.2 Antivenom Product Offered
  12.7.3 Flynn Pharma Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Flynn Pharma News
12.8 Vins Bioproducts
  12.8.1 Company Details
  12.8.2 Antivenom Product Offered
  12.8.3 Vins Bioproducts Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Vins Bioproducts News
12.9 Bharat Serums and Vaccines
  12.9.1 Company Details
  12.9.2 Antivenom Product Offered
  12.9.3 Bharat Serums and Vaccines Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Bharat Serums and Vaccines News
12.10 Serum Biotech
  12.10.1 Company Details
  12.10.2 Antivenom Product Offered
  12.10.3 Serum Biotech Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Serum Biotech News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antivenom
Table Product Specifications of Antivenom
Figure Antivenom Report Years Considered
Figure Market Research Methodology
Figure Global Antivenom Consumption Growth Rate 2013-2023 (K Vials)
Figure Global Antivenom Value Growth Rate 2013-2023 ($ Millions)
Table Antivenom Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Polyvalent antivenom
Table Major Players of Polyvalent antivenom
Figure Product Picture of Monovalent antivenom
Table Major Players of Monovalent antivenom
Table Global Consumption Sales by Type (2013-2018)
Table Global Antivenom Consumption Market Share by Type (2013-2018)
Figure Global Antivenom Consumption Market Share by Type (2013-2018)
Table Global Antivenom Revenue by Type (2013-2018) ($ million)
Table Global Antivenom Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Antivenom Value Market Share by Type (2013-2018)
Table Global Antivenom Sale Price by Type (2013-2018)
Figure Antivenom Consumed in Retail Pharmacies
Figure Global Antivenom Market: Retail Pharmacies (2013-2018) (K Vials)
Figure Global Antivenom Market: Retail Pharmacies (2013-2018) ($ Millions)
Figure Global Retail Pharmacies YoY Growth ($ Millions)
Figure Antivenom Consumed in Hospitals
Figure Global Antivenom Market: Hospitals (2013-2018) (K Vials)
Figure Global Antivenom Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Antivenom Consumed in Others
Figure Global Antivenom Market: Others (2013-2018) (K Vials)
Figure Global Antivenom Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Antivenom Consumption Market Share by Application (2013-2018)
Figure Global Antivenom Consumption Market Share by Application (2013-2018)
Table Global Antivenom Value by Application (2013-2018)
Table Global Antivenom Value Market Share by Application (2013-2018)
Figure Global Antivenom Value Market Share by Application (2013-2018)
Table Global Antivenom Sale Price by Application (2013-2018)
Table Global Antivenom Sales by Players (2016-2018) (K Vials)
Table Global Antivenom Sales Market Share by Players (2016-2018)
Figure Global Antivenom Sales Market Share by Players in 2016
Figure Global Antivenom Sales Market Share by Players in 2017
Table Global Antivenom Revenue by Players (2016-2018) ($ Millions)
Table Global Antivenom Revenue Market Share by Players (2016-2018)
Figure Global Antivenom Revenue Market Share by Players in 2016
Figure Global Antivenom Revenue Market Share by Players in 2017
Table Global Antivenom Sale Price by Players (2016-2018)
Figure Global Antivenom Sale Price by Players in 2017
Table Global Antivenom Manufacturing Base Distribution and Sales Area by Players
Table Players Antivenom Products Offered
Table Antivenom Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Antivenom Consumption by Regions 2013-2018 (K Vials)
Table Global Antivenom Consumption Market Share by Regions 2013-2018
Figure Global Antivenom Consumption Market Share by Regions 2013-2018
Table Global Antivenom Value by Regions 2013-2018 ($ Millions)
Table Global Antivenom Value Market Share by Regions 2013-2018
Figure Global Antivenom Value Market Share by Regions 2013-2018
Figure Americas Antivenom Consumption 2013-2018 (K Vials)
Figure Americas Antivenom Value 2013-2018 ($ Millions)
Figure APAC Antivenom Consumption 2013-2018 (K Vials)
Figure APAC Antivenom Value 2013-2018 ($ Millions)
Figure Europe Antivenom Consumption 2013-2018 (K Vials)
Figure Europe Antivenom Value 2013-2018 ($ Millions)
Figure Middle East & Africa Antivenom Consumption 2013-2018 (K Vials)
Figure Middle East & Africa Antivenom Value 2013-2018 ($ Millions)
Table Americas Antivenom Consumption by Countries (2013-2018) (K Vials)
Table Americas Antivenom Consumption Market Share by Countries (2013-2018)
Figure Americas Antivenom Consumption Market Share by Countries in 2017
Table Americas Antivenom Value by Countries (2013-2018) ($ Millions)
Table Americas Antivenom Value Market Share by Countries (2013-2018)
Figure Americas Antivenom Value Market Share by Countries in 2017
Table Americas Antivenom Consumption by Type (2013-2018) (K Vials)
Table Americas Antivenom Consumption Market Share by Type (2013-2018)
Figure Americas Antivenom Consumption Market Share by Type in 2017
Table Americas Antivenom Consumption by Application (2013-2018) (K Vials)
Table Americas Antivenom Consumption Market Share by Application (2013-2018)
Figure Americas Antivenom Consumption Market Share by Application in 2017
Figure United States Antivenom Consumption Growth 2013-2018 (K Vials)
Figure United States Antivenom Value Growth 2013-2018 ($ Millions)
Figure Canada Antivenom Consumption Growth 2013-2018 (K Vials)
Figure Canada Antivenom Value Growth 2013-2018 ($ Millions)
Figure Mexico Antivenom Consumption Growth 2013-2018 (K Vials)
Figure Mexico Antivenom Value Growth 2013-2018 ($ Millions)
Table APAC Antivenom Consumption by Countries (2013-2018) (K Vials)
Table APAC Antivenom Consumption Market Share by Countries (2013-2018)
Figure APAC Antivenom Consumption Market Share by Countries in 2017
Table APAC Antivenom Value by Countries (2013-2018) ($ Millions)
Table APAC Antivenom Value Market Share by Countries (2013-2018)
Figure APAC Antivenom Value Market Share by Countries in 2017
Table APAC Antivenom Consumption by Type (2013-2018) (K Vials)
Table APAC Antivenom Consumption Market Share by Type (2013-2018)
Figure APAC Antivenom Consumption Market Share by Type in 2017
Table APAC Antivenom Consumption by Application (2013-2018) (K Vials)
Table APAC Antivenom Consumption Market Share by Application (2013-2018)
Figure APAC Antivenom Consumption Market Share by Application in 2017
Figure China Antivenom Consumption Growth 2013-2018 (K Vials)
Figure China Antivenom Value Growth 2013-2018 ($ Millions)
Figure Japan Antivenom Consumption Growth 2013-2018 (K Vials)
Figure Japan Antivenom Value Growth 2013-2018 ($ Millions)
Figure Korea Antivenom Consumption Growth 2013-2018 (K Vials)
Figure Korea Antivenom Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Antivenom Consumption Growth 2013-2018 (K Vials)
Figure Southeast Asia Antivenom Value Growth 2013-2018 ($ Millions)
Figure India Antivenom Consumption Growth 2013-2018 (K Vials)
Figure India Antivenom Value Growth 2013-2018 ($ Millions)
Figure Australia Antivenom Consumption Growth 2013-2018 (K Vials)
Figure Australia Antivenom Value Growth 2013-2018 ($ Millions)
Table Europe Antivenom Consumption by Countries (2013-2018) (K Vials)
Table Europe Antivenom Consumption Market Share by Countries (2013-2018)
Figure Europe Antivenom Consumption Market Share by Countries in 2017
Table Europe Antivenom Value by Countries (2013-2018) ($ Millions)
Table Europe Antivenom Value Market Share by Countries (2013-2018)
Figure Europe Antivenom Value Market Share by Countries in 2017
Table Europe Antivenom Consumption by Type (2013-2018) (K Vials)
Table Europe Antivenom Consumption Market Share by Type (2013-2018)
Figure Europe Antivenom Consumption Market Share by Type in 2017
Table Europe Antivenom Consumption by Application (2013-2018) (K Vials)
Table Europe Antivenom Consumption Market Share by Application (2013-2018)
Figure Europe Antivenom Consumption Market Share by Application in 2017
Figure Germany Antivenom Consumption Growth 2013-2018 (K Vials)
Figure Germany Antivenom Value Growth 2013-2018 ($ Millions)
Figure France Antivenom Consumption Growth 2013-2018 (K Vials)
Figure France Antivenom Value Growth 2013-2018 ($ Millions)
Figure UK Antivenom Consumption Growth 2013-2018 (K Vials)
Figure UK Antivenom Value Growth 2013-2018 ($ Millions)
Figure Italy Antivenom Consumption Growth 2013-2018 (K Vials)
Figure Italy Antivenom Value Growth 2013-2018 ($ Millions)
Figure Russia Antivenom Consumption Growth 2013-2018 (K Vials)
Figure Russia Antivenom Value Growth 2013-2018 ($ Millions)
Figure Spain Antivenom Consumption Growth 2013-2018 (K Vials)
Figure Spain Antivenom Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Antivenom Consumption by Countries (2013-2018) (K Vials)
Table Middle East & Africa Antivenom Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Antivenom Consumption Market Share by Countries in 2017
Table Middle East & Africa Antivenom Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Antivenom Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Antivenom Value Market Share by Countries in 2017
Table Middle East & Africa Antivenom Consumption by Type (2013-2018) (K Vials)
Table Middle East & Africa Antivenom Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Antivenom Consumption Market Share by Type in 2017
Table Middle East & Africa Antivenom Consumption by Application (2013-2018) (K Vials)
Table Middle East & Africa Antivenom Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Antivenom Consumption Market Share by Application in 2017
Figure Egypt Antivenom Consumption Growth 2013-2018 (K Vials)
Figure Egypt Antivenom Value Growth 2013-2018 ($ Millions)
Figure South Africa Antivenom Consumption Growth 2013-2018 (K Vials)
Figure South Africa Antivenom Value Growth 2013-2018 ($ Millions)
Figure Israel Antivenom Consumption Growth 2013-2018 (K Vials)
Figure Israel Antivenom Value Growth 2013-2018 ($ Millions)
Figure Turkey Antivenom Consumption Growth 2013-2018 (K Vials)
Figure Turkey Antivenom Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Antivenom Consumption Growth 2013-2018 (K Vials)
Figure GCC Countries Antivenom Value Growth 2013-2018 ($ Millions)
Table Antivenom Distributors List
Table Antivenom Customer List
Figure Global Antivenom Consumption Growth Rate Forecast (2018-2023) (K Vials)
Figure Global Antivenom Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Antivenom Consumption Forecast by Countries (2018-2023) (K Vials)
Table Global Antivenom Consumption Market Forecast by Regions
Table Global Antivenom Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Antivenom Value Market Share Forecast by Regions
Figure Americas Antivenom Consumption 2018-2023 (K Vials)
Figure Americas Antivenom Value 2018-2023 ($ Millions)
Figure APAC Antivenom Consumption 2018-2023 (K Vials)
Figure APAC Antivenom Value 2018-2023 ($ Millions)
Figure Europe Antivenom Consumption 2018-2023 (K Vials)
Figure Europe Antivenom Value 2018-2023 ($ Millions)
Figure Middle East & Africa Antivenom Consumption 2018-2023 (K Vials)
Figure Middle East & Africa Antivenom Value 2018-2023 ($ Millions)
Figure United States Antivenom Consumption 2018-2023 (K Vials)
Figure United States Antivenom Value 2018-2023 ($ Millions)
Figure Canada Antivenom Consumption 2018-2023 (K Vials)
Figure Canada Antivenom Value 2018-2023 ($ Millions)
Figure Mexico Antivenom Consumption 2018-2023 (K Vials)
Figure Mexico Antivenom Value 2018-2023 ($ Millions)
Figure Brazil Antivenom Consumption 2018-2023 (K Vials)
Figure Brazil Antivenom Value 2018-2023 ($ Millions)
Figure China Antivenom Consumption 2018-2023 (K Vials)
Figure China Antivenom Value 2018-2023 ($ Millions)
Figure Japan Antivenom Consumption 2018-2023 (K Vials)
Figure Japan Antivenom Value 2018-2023 ($ Millions)
Figure Korea Antivenom Consumption 2018-2023 (K Vials)
Figure Korea Antivenom Value 2018-2023 ($ Millions)
Figure Southeast Asia Antivenom Consumption 2018-2023 (K Vials)
Figure Southeast Asia Antivenom Value 2018-2023 ($ Millions)
Figure India Antivenom Consumption 2018-2023 (K Vials)
Figure India Antivenom Value 2018-2023 ($ Millions)
Figure Australia Antivenom Consumption 2018-2023 (K Vials)
Figure Australia Antivenom Value 2018-2023 ($ Millions)
Figure Germany Antivenom Consumption 2018-2023 (K Vials)
Figure Germany Antivenom Value 2018-2023 ($ Millions)
Figure France Antivenom Consumption 2018-2023 (K Vials)
Figure France Antivenom Value 2018-2023 ($ Millions)
Figure UK Antivenom Consumption 2018-2023 (K Vials)
Figure UK Antivenom Value 2018-2023 ($ Millions)
Figure Italy Antivenom Consumption 2018-2023 (K Vials)
Figure Italy Antivenom Value 2018-2023 ($ Millions)
Figure Russia Antivenom Consumption 2018-2023 (K Vials)
Figure Russia Antivenom Value 2018-2023 ($ Millions)
Figure Spain Antivenom Consumption 2018-2023 (K Vials)
Figure Spain Antivenom Value 2018-2023 ($ Millions)
Figure Egypt Antivenom Consumption 2018-2023 (K Vials)
Figure Egypt Antivenom Value 2018-2023 ($ Millions)
Figure South Africa Antivenom Consumption 2018-2023 (K Vials)
Figure South Africa Antivenom Value 2018-2023 ($ Millions)
Figure Israel Antivenom Consumption 2018-2023 (K Vials)
Figure Israel Antivenom Value 2018-2023 ($ Millions)
Figure Turkey Antivenom Consumption 2018-2023 (K Vials)
Figure Turkey Antivenom Value 2018-2023 ($ Millions)
Figure GCC Countries Antivenom Consumption 2018-2023 (K Vials)
Figure GCC Countries Antivenom Value 2018-2023 ($ Millions)
Table Global Antivenom Consumption Forecast by Type (2018-2023) (K Vials)
Table Global Antivenom Consumption Market Share Forecast by Type (2018-2023)
Table Global Antivenom Value Forecast by Type (2018-2023) ($ Millions)
Table Global Antivenom Value Market Share Forecast by Type (2018-2023)
Table Global Antivenom Consumption Forecast by Application (2018-2023) (K Vials)
Table Global Antivenom Consumption Market Share Forecast by Application (2018-2023)
Table Global Antivenom Value Forecast by Application (2018-2023) ($ Millions)
Table Global Antivenom Value Market Share Forecast by Application (2018-2023)
Table CSL Behring Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Behring Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CSL Behring Antivenom Market Share (2016-2018)
Table Merck & Co., Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co., Inc. Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck & Co., Inc. Antivenom Market Share (2016-2018)
Table BTG Plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BTG Plc Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
Figure BTG Plc Antivenom Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Antivenom Market Share (2016-2018)
Table Haffkine Bio-Pharmaceutical Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Haffkine Bio-Pharmaceutical Corporation Antivenom Market Share (2016-2018)
Table Rare Disease Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Rare Disease Therapeutics Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Rare Disease Therapeutics Antivenom Market Share (2016-2018)
Table Flynn Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Flynn Pharma Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Flynn Pharma Antivenom Market Share (2016-2018)
Table Vins Bioproducts Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Vins Bioproducts Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Vins Bioproducts Antivenom Market Share (2016-2018)
Table Bharat Serums and Vaccines Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bharat Serums and Vaccines Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bharat Serums and Vaccines Antivenom Market Share (2016-2018)
Table Serum Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Serum Biotech Antivenom Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Serum Biotech Antivenom Market Share (2016-2018)